Skip to main content
Caplight Logo









Fibrocor Therapeutics

Fibrocor Therapeutics

Private
TorontoHealthcare & Life Scienceshttps://fibrocor.com/

Last Round

Strategic

Jan 15, 2020

Total Funding Raised

$2.1M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Fibrocor Therapeutics is a biotechnology company that develops first-in-class therapeutics targeting fibrotic diseases, with an initial focus on kidney diseases such as Alport Syndrome and ADPKD.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoveryfibrotic kidney diseaseprecision medicinebiomarker discoverytherapeutic pipelineAlport SyndromeADPKDAutosomal Dominant Polycystic Kidney Diseasesmall molecule inhibitorbiotech startupdrug licensingtarget validationbiopharma partnershipclinical-stage biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Fibrocor Therapeutics Comparables

Compare Fibrocor Therapeutics with similar companies based on industry and business-model similarity.

Fibrocor Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Evotec
80%
Mirador Therapeutics
80%
ENYO Pharma
78%

Fibrocor Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicJan 15, 2020
SeedJan 17, 2017

Key People

Founding team and executive leadership

William Newsome

President & CEO

Executive Team

John Vittoria

Interim CFO

Executive Team

Fibrocor Therapeutics Investors

Notable investors and investment history

Fibrocor Therapeutics investors
InvestorRounds
TIAPSeed
BioGeneration VenturesStrategic

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 282% MoM, reaching 2.5K.

  • Jan 15, 2020

    Raised capital from BioGeneration Ventures and Lakefront Biotherapeutics NV.

Fibrocor Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Fibrocor Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Fibrocor Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersToronto
Employee Range9
Year Founded2017
Last FundingJan 15, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?